Acute Respiratory Failure
Acute Respiratory Failure
Acute Respiratory Failure
Definition
or
Hypoxaemia on its own does not always mean respiratory failure, for
example, if the subject is at altitude or has a right to left shunt due to
congenital heart disease.
We are concerned only with ARF, one of the most dramatic and life
threatening emergencies that the casualty officer and the house office
may have to deal with in the hospital setting.
Pathophysiology
Clinical Picture
The clinical picture varies with the cause but any of those mentioned
in Table 1 leads to a deterioration in the patient's respiratory gas
exchange. The subsequent changes which occur in blood gases,
particularly carbon dioxide, cause stimulation of the medullary chemo-
receptor and compensatory mechanisms to be activated. The patient
becomes aware of the necessity to breathe, and as the precipitating
cause progresses, exhibits overt signs of distress, i.e. dyspnoea.
Eventually blood gases can no longer be kept in the normal range and
ARF supervenes.
Examples
Site
Respiratory centre Depressant drugs, opiates; traumatic and
(CNS) ischaemic lesions
Loss of respiratory sensitivity to CO2
Spinal cord and Spinal injury, Guillain Barre, poliomyelitis
peripheral nerves
Neuromuscular junction Myasthenia, neuromuscular blocking drugs
Muscle Myopathies, respiratory muscle fatigue in
COPD
Pleura and thoracic cage Flail chest, pneumothorax, haemothorax
Deformities, trauma (e.g. rib fractures),
loss of optimal shape due to chronic lung
hyperinflation
Airways Extrathoracic: foreign bodies, croup
Intrathoracic: asthma, bronchiolitis,
bronchitis
Gaseous exchange Emphysema, pulmonary oedema, ARDS,
pneumonia
Lung vasculature Pulmonary embolus, ARDS
1 Hypoxia:
2 Hypercarbia:
Diagnosis
Treatment
These two are inextricably linked. The causes of ARF are many and
varied as are the requisite therapies. If treatment of the underlying
cause is not successful (i.e. steroids, bronchodilators in asthma;
physiotherapy, antibiotics, mucolytics, bronchodilators in acute or
chronic bronchitis), then the carbon dioxide tension will begin to rise,
necessitating intermittent positive pressure ventilation (IPPV). There is
little place for respiratory stimulants, except perhaps narcotic
antagonists in opiate overdose. NB Infection is a cause of exacerbation
of ARF in bronchitics in less than 50% of cases. Other causes such as
heart failure, dysrthymias and pneumothorax must be excluded and
treated where necessary.
Despite the fact that there are many causes of ARF, anaesthetists in
ICU are faced with a relatively small number of problems, which
occur frequently.
Upper airway obstruction in the small child represents one of the most
life-threatening situations in clinical medicine. Croup means literally
'noisy breathing' and is due to upper airway obstruction,
conventionally delineated into supra-and subglottic. The most
common causes are infectious and traumatic.
(1) Infectious
The diagnosis is made on the history and clinical findings, and as the
child (usually 3 to 7 years old) may completely obstruct at any time,
he or she must be taken immediately to the operating theatre with an
experienced anaesthetist and surgeon prepared for endotracheal
intubation (ETI) or tracheotomy. This is usually performed under
general anaesthesia as attempted manipulations to visualise the
epiglottis in the awake patient often results in total obstruction and
death. Following preferably nasotracheal intubation, the child is
sedated and treated for Haemophilus influenzae infection with
ampicillin and other appropriate antibiotics together with
humidification of inspired gases.
(2) Trauma
By the time the patient with an acute asthmatic attack reaches the ICU,
the anaesthetist is faced with one of the most difficult management
problems. The patient is often exhausted, tachycardic, hypoxic,
hypercarbic, acidotic and dehydrated, yet needs intubation and
ventilation to restore reasonable blood gases. Attempting to intubate
the patient 'awake' may precipitate cardiovascular collapse. Following
intubation, ventilation is usually extremely difficult necessitating high
inflation pressures which can only be lowered by prolonging
inspiration, and yet air trapping requires that expiration is also
prolonged. This conundrum requires considerable compromise with
ventilator settings and can often only be accommodated by accepting
relatively high PaCO2 levels.
Only guidelines can be given, but in cases where the patient has had
frequent previous admissions with IPPV treatment, progressive lung
damage can be anticipated so that further periods of IPPV may be
unwarranted. This is also applicable to cases where the patient is
housebound and/or breathless at rest. However, recent studies suggest
that the patient with ARF due to COPD has as good a chance of
weaning from mechanical ventilation s a patient who needs IPPV from
an acute attack of asthma.
In recent years, it has become evident that the lung can be injured
primarily (as in aspiration pneumonitis) as well as by a secondary
process in severe illness or trauma. Generally speaking it is the
vascular endothelium (either bronchial venular or capillary) which is
affected. Damage from any of the causes below results in loss of
membrane integrity and thus increased permeability to fluid and
protein. This leaks into the interstitial space and lymphatics, producing
an exudative 'non' cardiogenic pulmonary oedema', with a
characteristic 'fluffy' appearance on chest X-ray. It is distinguished
from 'cardiogenic pulmonary oedema', by demonstration of a normal
or low pulmonary capillary wedge pressure, and from oedema due to a
low colloid oncotic pressure by demonstration of a serum albumin of
>30 g l-1. A pronounced decrease in functional residual capacity
(FRC) and compliance occurs, with a resulting increased work of
breathing and dyspnoea. This together with the associated vascular
damage results in an imbalance of ventilation and perfusion, with
hypoxia and increase in dead space. A pronounced inflammatory and
fibrotic stage may supervene and lead to permanent lung damage.
Previous Page